Upgrades
- According to Baird, the prior rating for Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) was changed from Neutral to Outperform. Ultragenyx Pharmaceutical earned $2.43 in the third quarter, compared to $1.08 in the year-ago quarter. At the moment, the stock has a 52-week-high of $88.12 and a 52-week-low of $36.67. Ultragenyx Pharmaceutical closed at $40.59 at the end of the last trading period.
- According to Piper Sandler, the prior rating for Alkermes PLC (NASDAQ:ALKS) was changed from Neutral to Overweight. In the third quarter, Alkermes showed an EPS of $0.02, compared to $0.14 from the year-ago quarter. The current stock performance of Alkermes shows a 52-week-high of $32.79 and a 52-week-low of $21.75. Moreover, at the end of the last trading period, the closing price was at $24.06.
- For Freshpet Inc (NASDAQ:FRPT), Citigroup upgraded the previous rating of Sell to Neutral. For the third quarter, Freshpet had an EPS of $0.39, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $118.77 and a 52-week-low of $36.02. At the end of the last trading period, Freshpet closed at $63.12.
- According to William Blair, the prior rating for Lindblad Expeditions Holdings Inc (NASDAQ:LIND) was changed from Market Perform to Outperform. In the third quarter, Lindblad Expeditions showed an EPS of $0.18, compared to $0.50 from the year-ago quarter. The stock has a 52-week-high of $19.13 and a 52-week-low of $5.91. At the end of the last trading period, Lindblad Expeditions closed at $9.32.
